|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.306
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.257
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.196
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.172
|
|
|
|
negative regulation of triglyceride biosynthetic process
|
GO:0010868 |
2 |
0.158
|
|
|
|
positive regulation of fibroblast growth factor receptor signaling pathway
|
GO:0045743 |
3 |
0.135
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.134
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.123
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.110
|
|
|
|
exosomal secretion
|
GO:1990182 |
1 |
0.105
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.101
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.094
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.089
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.088
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.079
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.079
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.078
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.075
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.075
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.072
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.069
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.069
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.068
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.062
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.061
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.059
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.059
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.057
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.056
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.056
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.054
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.054
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.054
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.053
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.052
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.052
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.052
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.050
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.050
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.050
|
|
|
|
glial cell fate determination
|
GO:0007403 |
3 |
0.049
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.047
|
|
|
|
negative regulation of interleukin 5 production
|
GO:0032714 |
4 |
0.047
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.047
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.046
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.046
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.046
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.046
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.046
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.045
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.045
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.045
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.045
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.044
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.044
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.043
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.042
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.041
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.041
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.040
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.040
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.040
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.040
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.039
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.039
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.039
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.039
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.039
|
|
|
|
negative regulation of triglyceride metabolic process
|
GO:0090209 |
4 |
0.039
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.039
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.038
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.038
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.037
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.037
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.037
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.037
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.036
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.036
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.036
|
|
|
|
establishment of protein localization to vacuole
|
GO:0072666 |
4 |
0.036
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.036
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.036
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.035
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.035
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.035
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.035
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.035
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.035
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.035
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.034
|
|
|
|
regulation of toll signaling pathway
|
GO:0008592 |
1 |
0.034
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.034
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.034
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.033
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.033
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.033
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.033
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.033
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.032
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.032
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.032
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.032
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.031
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.031
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.031
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.031
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.031
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.031
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.031
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.030
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.030
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.030
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.030
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.030
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.030
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.029
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.029
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.029
|
|
|
|
protein localization to vacuole
|
GO:0072665 |
4 |
0.029
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.028
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.028
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.028
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.028
|
|
|
|
positive regulation of protein autophosphorylation
|
GO:0031954 |
4 |
0.028
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.028
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.027
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.027
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.027
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.027
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.026
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.026
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.026
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.026
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.026
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.026
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.026
|
|
|
|
protein localization to cell junction
|
GO:1902414 |
3 |
0.026
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.026
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.025
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.025
|
|
|
|
positive regulation of exocytosis
|
GO:0045921 |
20 |
0.025
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.025
|
|
|
|
neuroblast fate determination
|
GO:0007400 |
1 |
0.025
|
|
|
|
protein targeting to vacuole
|
GO:0006623 |
3 |
0.025
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.025
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.025
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.024
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.024
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.024
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.024
|
|
|
|
glial cell fate commitment
|
GO:0021781 |
14 |
0.024
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.024
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.024
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.024
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.024
|
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.023
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.023
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.023
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.023
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.023
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.023
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.023
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.023
|
|
|
|
epidermal growth factor receptor signaling pathway
|
GO:0007173 |
28 |
0.023
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.023
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.023
|
|
|
|
autophagy
|
GO:0006914 |
45 |
0.022
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.022
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.022
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.022
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.022
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.022
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.022
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.022
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.022
|
|
|
|
mrna transcription from rna polymerase ii promoter
|
GO:0042789 |
4 |
0.022
|
|
|
|
neuroblast fate commitment
|
GO:0014017 |
1 |
0.021
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.021
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.021
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.021
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.021
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.021
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.021
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.021
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.021
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.021
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.021
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.021
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.020
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.020
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.020
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.020
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.020
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.020
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.020
|
|
|
|
cell cycle switching
|
GO:0060184 |
1 |
0.020
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.020
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.020
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.020
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.020
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.020
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.020
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.020
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.020
|
|
|
|
germline cell cycle switching mitotic to meiotic cell cycle
|
GO:0051729 |
1 |
0.020
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.019
|
|
|
|
secretory granule organization
|
GO:0033363 |
20 |
0.019
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.019
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.019
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.019
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.019
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.019
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.019
|
|
|
|
eye photoreceptor cell development
|
GO:0042462 |
31 |
0.019
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.019
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.019
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.019
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.019
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.019
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.019
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.019
|
|
|
|
early endosome to late endosome transport
|
GO:0045022 |
2 |
0.018
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.018
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.018
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.018
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.018
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.018
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.018
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.018
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.018
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.018
|
|
|
|
cytokinetic process
|
GO:0032506 |
2 |
0.018
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.018
|
|
|
|
positive regulation of dna biosynthetic process
|
GO:2000573 |
4 |
0.018
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.018
|
|
|
|
negative regulation of fatty acid metabolic process
|
GO:0045922 |
10 |
0.018
|
|
|
|
triglyceride biosynthetic process
|
GO:0019432 |
17 |
0.018
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.018
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.018
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.018
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.017
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.017
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
35 |
0.017
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.017
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.017
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.017
|
|
|
|
atrioventricular valve morphogenesis
|
GO:0003181 |
13 |
0.017
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.017
|
|
|
|
regulation of cellular response to insulin stimulus
|
GO:1900076 |
30 |
0.017
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.017
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.017
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.017
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.017
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.017
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.017
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.017
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.017
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.017
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.017
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.017
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.017
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.016
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.016
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.016
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.016
|
|
|
|
fc receptor mediated inhibitory signaling pathway
|
GO:0002774 |
1 |
0.016
|
|
|
|
regulation of cell fate commitment
|
GO:0010453 |
19 |
0.016
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.016
|
|
|
|
positive regulation of protein ubiquitination
|
GO:0031398 |
27 |
0.016
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.016
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.016
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.016
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.016
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.016
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.016
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.016
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.016
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.016
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.016
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.016
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.016
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.016
|
|
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
30 |
0.016
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.015
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.015
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.015
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.015
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.015
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.015
|
|
|
|
neutral lipid biosynthetic process
|
GO:0046460 |
18 |
0.015
|
|
|
|
heterophilic cell cell adhesion via plasma membrane cell adhesion molecules
|
GO:0007157 |
20 |
0.015
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.015
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.015
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.015
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.015
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.015
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.015
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.015
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.015
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.015
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.015
|
|
|
|
ventral trunk neural crest cell migration
|
GO:0036486 |
4 |
0.014
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.014
|
|
|
|
protein targeting to lysosome
|
GO:0006622 |
2 |
0.014
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.014
|
|
|
|
cell cycle switching mitotic to meiotic cell cycle
|
GO:0051728 |
1 |
0.014
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.014
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.014
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.014
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.014
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.014
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.014
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.014
|
|
|
|
acylglycerol biosynthetic process
|
GO:0046463 |
18 |
0.014
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.014
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.014
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.014
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.014
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.014
|
|
|
|
sympathetic neuron projection guidance
|
GO:0097491 |
4 |
0.014
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.014
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.014
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.014
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.014
|
|
|
|
interleukin 10 secretion
|
GO:0072608 |
4 |
0.014
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.014
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
52 |
0.013
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.013
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.013
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.013
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.013
|
|
|
|
positive regulation of immature t cell proliferation
|
GO:0033091 |
4 |
0.013
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.013
|
|
|
|
regulation of interleukin 10 production
|
GO:0032653 |
21 |
0.013
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.013
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.013
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.013
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.013
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.013
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.013
|
|
|
|
positive regulation of fibroblast proliferation
|
GO:0048146 |
20 |
0.013
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.013
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.013
|
|
|
|
regulation of cd4 positive alpha beta t cell activation
|
GO:2000514 |
24 |
0.013
|
|
|
|
regulation of osteoclast differentiation
|
GO:0045670 |
36 |
0.013
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.013
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.013
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.013
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.013
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.013
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.013
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.013
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.013
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.013
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.013
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.013
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
34 |
0.012
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.012
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.012
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.012
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.012
|
|
|
|
regulation of gluconeogenesis
|
GO:0006111 |
30 |
0.012
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.012
|
|
|
|
pro t cell differentiation
|
GO:0002572 |
3 |
0.012
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.012
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.012
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.012
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.012
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.012
|
|
|
|
regulation of b cell mediated immunity
|
GO:0002712 |
37 |
0.012
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.012
|
|
|
|
female meiotic division
|
GO:0007143 |
21 |
0.012
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.012
|
|
|
|
regulation of cd4 positive alpha beta t cell differentiation
|
GO:0043370 |
21 |
0.012
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.012
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.012
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.012
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.012
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.012
|
|
|
|
negative regulation of cytokine biosynthetic process
|
GO:0042036 |
13 |
0.012
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.012
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.012
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.012
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.012
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.012
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.012
|
|
|
|
negative regulation of glycoprotein metabolic process
|
GO:1903019 |
3 |
0.012
|
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
2 |
0.012
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.012
|
|
|
|
negative regulation of creb transcription factor activity
|
GO:0032792 |
2 |
0.012
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.012
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.012
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.012
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.012
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.012
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.012
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.012
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.012
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.012
|
|
|
|
positive regulation of protein binding
|
GO:0032092 |
29 |
0.012
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.012
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.012
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.012
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.011
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.011
|
|
|
|
protein localization to adherens junction
|
GO:0071896 |
2 |
0.011
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.011
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.011
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.011
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.011
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.011
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.011
|
|
|
|
membrane invagination
|
GO:0010324 |
17 |
0.011
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.011
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.011
|
|
|
|
positive regulation of notch signaling pathway
|
GO:0045747 |
18 |
0.011
|
|
|
|
cell migration involved in endocardial cushion formation
|
GO:0003273 |
3 |
0.011
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.011
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.011
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.011
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.011
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.011
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.011
|
|
|
|
peptidyl tyrosine dephosphorylation
|
GO:0035335 |
23 |
0.011
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.011
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.011
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.011
|
|
|
|
dna replication
|
GO:0006260 |
52 |
0.011
|
|
|
|
positive regulation of dendritic cell apoptotic process
|
GO:2000670 |
3 |
0.011
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.011
|
|
|
|
stem cell fate determination
|
GO:0048867 |
2 |
0.011
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.011
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.011
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.011
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.011
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.011
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.011
|
|
|
|
negative regulation of cell fate commitment
|
GO:0010454 |
8 |
0.011
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.011
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.011
|
|
|
|
transforming growth factor beta1 production
|
GO:0032905 |
3 |
0.011
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.011
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.011
|
|
|
|
regulation of membrane protein ectodomain proteolysis
|
GO:0051043 |
3 |
0.011
|
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.011
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.010
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.010
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.010
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.010
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.010
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.010
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.010
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.010
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.010
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.010
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.010
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.010
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.010
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.010
|
|
|
|
positive regulation of t cell mediated immunity
|
GO:0002711 |
24 |
0.010
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.010
|
|
|
|
ral protein signal transduction
|
GO:0032484 |
2 |
0.010
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.010
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.010
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.010
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.010
|
|
|
|
positive regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0045737 |
6 |
0.010
|
|
|
|
hyaluronan metabolic process
|
GO:0030212 |
4 |
0.010
|
|
|
|
regulation of hepatocyte proliferation
|
GO:2000345 |
6 |
0.010
|
|